Drugs / RO7268489
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07282574 | Mar 2026 → May 2028 expected | multiple sclerosis | Hoffmann-La Roche | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO7268489 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07282574 ↗ |
| Action | Inhibit | “Monoacylglycerol Lipase Inhibitor” NCT07282574 ↗ |